Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Weekly Oral Topotecan in Gynecologic Malignancies

NCT00842452 is registered in ClinicalTrials.gov with Steven Waggoner, MD as lead sponsor.

NCT NCT00842452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00842452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Weekly Oral Topotecan in Gynecologic Malignancies
Lead sponsor
Steven Waggoner, MD
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2009
Completion date
April 30, 2011
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, fallopian tube cancer, ovarian cancer, sarcoma, vaginal cancer, vulvar cancer